Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope Share
SHARE YOUR STORY!
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW

1459 Search Results Found

You searched for: "study of the week"
  1. Home>
  2. Search results for “study of the week”>
  3. Page 17
Editor’s Choice: Balance Awareness Week and Study Updates

Editor’s Choice: Balance Awareness Week and Study Updates

Happy Friday! Sept. 13-19 is Balance Awareness Week. It's intended to bring attention to balance-related vestibular disorders such as Meniere’s disease and vestibular migraine. Looking for ways to help out?…

Continue Reading Editor’s Choice: Balance Awareness Week and Study Updates
A Recent Study Could Reveal A New Once-A-Week Treatment For Short Bowel Syndrome

A Recent Study Could Reveal A New Once-A-Week Treatment For Short Bowel Syndrome

According to an article from GlobeNewswire, new clinical evidence supports the use of gelpaglutide as a once-weekly treatment for short bowel syndrome. Zealand Pharma completed a Phase I clinical trial…

Continue Reading A Recent Study Could Reveal A New Once-A-Week Treatment For Short Bowel Syndrome
Enrollment Complete for Phase 3 Study Evaluating aPAP Treatment Molgramostim

Enrollment Complete for Phase 3 Study Evaluating aPAP Treatment Molgramostim

Clinical-stage biopharmaceutical company Savara Inc. was founded on a desire to develop innovative therapies for people living with rare respiratory diseases. The company's work over the past few years centers…

Continue Reading Enrollment Complete for Phase 3 Study Evaluating aPAP Treatment Molgramostim
Study: Specialized Immune Responses Keep Some People from Contracting COVID-19

Study: Specialized Immune Responses Keep Some People from Contracting COVID-19

The COVID-19 pandemic took our world by storm. COVID-19 affected hundreds of millions of people globally and was associated with tens of millions of deaths. Today, people are still dying…

Continue Reading Study: Specialized Immune Responses Keep Some People from Contracting COVID-19
Tardive Dyskinesia: Phase 3 Study Results Indicate Improvement with Use of INGREZZA®

Tardive Dyskinesia: Phase 3 Study Results Indicate Improvement with Use of INGREZZA®

This week Neurocrine Biosciences announced the results of its KINECT®-4 Phase 3 study of INGREZZA® capsules. Results of the trial were published in the Journal of Clinical Psychopharmacology. A long-term…

Continue Reading Tardive Dyskinesia: Phase 3 Study Results Indicate Improvement with Use of INGREZZA®
Encouraging Results from a Phase 2 Study of IL-2 to Treat Alzheimer’s Patients

Encouraging Results from a Phase 2 Study of IL-2 to Treat Alzheimer’s Patients

BioSpace recently published a press release discussing the interim results highlighting a Coya Therapeutics’ study. The study evaluates the safety, tolerability, and biological activity of LD IL-2 in 38 patients…

Continue Reading Encouraging Results from a Phase 2 Study of IL-2 to Treat Alzheimer’s Patients
AbbVie Releases Positive Topline Results from Upadacitinib Study for Giant Cell Arteritis

AbbVie Releases Positive Topline Results from Upadacitinib Study for Giant Cell Arteritis

RINVOQ (upadacitinib) is a Janus Kinase inhibitor that is currently approved to treat a variety of conditions: moderate to severe atopic dermatitis, active psoriatis arthritis, moderate to severe rheumatoid arthritis,…

Continue Reading AbbVie Releases Positive Topline Results from Upadacitinib Study for Giant Cell Arteritis
First Patient Dosed in Clinical Study Evaluating Kamuvadine-8 for Geographic Atrophy

First Patient Dosed in Clinical Study Evaluating Kamuvadine-8 for Geographic Atrophy

Do you know what your macula does? The macula, or the central portion of your retina, plays a role in your central vision; this is required for reading, facial recognition,…

Continue Reading First Patient Dosed in Clinical Study Evaluating Kamuvadine-8 for Geographic Atrophy
  • Go to the previous page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 183
  • Go to the next page

Featured


Picture of Family


Metastatic Breast Cancer: Navigating Grief


Picture of Ralph Family walking


Rethinking What It Means to Live With Acromegaly


Illustration of mentor program members


The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info